Amplify Treatments, Testing And Advancements ETF MRNA Holdings History
Number of Shares
3,794.00
Current Holdings Value*
$450,540.00
% of Portfolio
4.93%
Total Estimate Gain
$-179,393.52
% of Total Estimate Gain
-25.01%
Amplify Treatments, Testing and Advancements ETF's Moderna Inc Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 3,794.00 shares of Moderna Inc(MRNA), totaling $450,540.00. This investment constitutes 4.93% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding Moderna Inc(MRNA) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $126.55 for 3,322.00 shares. Based on historical transaction data and MRNA's current price of $30.97, Amplify Treatments, Testing and Advancements ETF's estimated gain on his MRNA holdings is $-179,393.52, reflecting a -25.01% gain to date.
Amplify Treatments, Testing and Advancements ETF MRNA ($30.97) Holding Chart
Amplify Treatments, Testing and Advancements ETF MRNA ($30.97) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1